Type 2 diabetes mellitus (T2DM) is one of the most threatening, non-communicable ailments worldwide.
Introduction
Type-2 Diabetes Mellitus (T2DM) has shown an alarming upswing globally and has been positioned as the h prominent origin of death in the world. This disease is related to deliberate complications including diabetic neuropathy, peripheral vascular disease, and diabetic neuropathy and renal failure.
1,2
The present scenario of rapid worldwide increase in diabetes cases are associated with the rapid advances in the unhealthy lifestyle of human, urbanization, and aging; global assessment of diabetics for the past three decades has shown an increase in the cases from 153 million to 368 million. Currently, 382 million cases of diabetes have been estimated in 2016, and they are speculated to rise to 592 million by the year 2035.
3,4
Treatment of T2DM using medicinally active plants is in practice all over the world. Momordica charantia, also known as bitter gourd, balsam pear, melon, and karela, is a wellknown nutritious plant used for the treatment of diabetes amongst the indigenous people of Asia, South America, India, and the Caribbean.
5-8 MC's fruit has a distinguishing bitter taste, which gets more pronounced as it ripens; therefore, it is called bitter melon or bitter gourd. Biochemical and animal model experiments have produced abundant data and hypotheses accounting for the anti-diabetic effects of the MC extract. In comparison, clinical studies with human subjects are sparse and low quality in design. An increasing number of patients opt for nanoherbal remedies driven by a combination of factors including higher bioavailability, lower dosage, and greater compliance. Many ndings have depicted the key role of metals in glucose metabolism and the relationship of their inadequacy with diabetes. Silver, [9] [10] [11] [12] [13] vanadium, chromium, magnesium, and zinc oxide have been reported to play a role in the reduction of glucose levels and included in diabetes therapy and possess many other pharmacological properties. The valuable role of zinc in the treatment of diabetes has been embroiled via investigations of zinc supplies in diabetic rats.
14,15 Although CeO 2 is an important metal in a huge number of metabolic processes, there are no data about the effectiveness of this metal in glucose reduction using animal models. Ag NPs have already been proven to possess antidiabetic activity in our previous study. 16 From current research in the eld of herbal nanomedicine, it is clearly shown that the green synthesized nanoparticles are effective than the crude extracts since the nanoparticles offer some advantages, such as higher surface area, high solubility, and enhanced therapeutic activity. This encouraged us to study the therapeutic effect of the MC extract in comparison with that of the ZnO NPs, CeO 2 NPs, and Ag NPs.
Experimental details

Materials
Momordica charantia (MC) fruits were obtained from JNT University premises. Zinc nitrate (Sigma Aldrich), cerium nitrate (Sigma Aldrich), ethanol, and distilled water were used in the synthesis process in their pure form without any further modication.
Plant extraction: Soxhlet extraction
The MC fruits were washed to remove the adhering mud particles and possible impurities. Then, they were dried under sunlight for a week to completely remove the moisture. The fruits were cut into small pieces, powdered in a mixer, and then sieved using a 20 mesh sieve to obtain a uniform size range. The coarse powder was packed in a Soxhlet apparatus and allowed to undergo solvent extraction using water. The aqueous extract was concentrated using a rota evaporator, and then, the resultant product was stored in a desiccator until further use. 17 The nature of the extract was as follows; state: semi solid; color: dark green; and solubility: soluble in water.
Biological synthesis of ZnO, CeO 2 , and Ag NPs
The ZnO, CeO 2 , and Ag NPs nanoparticles were synthesized using the simple green synthesis method. In this method, ZnO and CeO 2 were synthesized by adding distilled water to 0.5 mM of precursor (zinc nitrate for ZnO and cerium nitrate for CeO 2 ) under constant magnetic stirring. Then, 25 ml of MC aqueous extract was added dropwise to the abovementioned solution, and this mixed solution was then placed on a magnetic stirrer for 2 h at 70 C. The resultant solution was placed in an autoclave for 5 cycles (1 cycle ¼ 20 minutes). Aer terminating the reaction, the semi liquid, light brown precipitate obtained was placed in a microwave until the solvent evaporated. The precipitate was taken out and thoroughly washed with distilled water followed by ethanol to get rid of the impurities; then, a powder of ZnO and CeO 2 nanoparticles was obtained. The resulting ZnO and CeO 2 powder was annealed at 400 C for 4 h.
18,19
The procedure of Ag NPs synthesis was well described in our previous study using a medicinally active plant extract. 16 The Ag NPs were synthesized by adding 10 ml of the ltered plant extract to the conical asks containing 90 ml of silver nitrate solution, and the mixed solution was vigorously stirring using a magnetic stirrer. The conical asks were then incubated at room temperature for 24 h. The solution changed from light green to dark brown; this indicated the formation of Ag NPs. The change in the color indicated the formation of Ag NPs. The dark brown-colored solution was centrifuged at 4000 RPM for 30 minutes.
Characterization of the green-synthesized nanoparticles
The nanoparticles were characterized by various methods such as X-ray diffraction, Fourier transform infrared spectroscopy, particle size analysis, and scanning electron microscopy to determine the crystalline nature, functional groups present, average particle size, and morphology of the ZnO, CeO 2 , and Ag NPs, respectively.
In vivo sub-acute oral toxicity study Female Swiss albino mice weighing between 20 and 30 g were used and bred in the Central Animal House facility of Pullareddy Institute of Pharmacy, Hyderabad (Reg. no. 1684/PO/a/ 13/CPCSEA). All the animals were maintained under standard laboratory conditions i.e. temperature of 20 AE 2 C; relative humidity of 45-55%; and a 12 : 12 hour light/dark cycle. The animals had free access to a standard pellet diet (Amrut feeds, Bangalore), with water provided ad libitum under strict hygienic conditions. The animals were divided into 10 groups of 6 animals each. The normal control received normal distilled water (2 ml kg À1 , p.o.), and the other groups received a graded dose (800, 1000, and 2000 mg kg À1 ) of the Zn O NPs, CeO 2 , and Ag NPs (3 doses of each test drug), respectively. Immediately aer dosing, the animals were continuously observed for the rst 4 hours for any behavioural changes and death, if any, intermittently for the next 6 h, and then again at 24 h aer dosing. They were then kept under observation up to 28 days aer drug administration to nd out the mortality, if any.
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The observations were made twice daily: one at 8 a.m. and another at 8 p.m.
Histopathology study
On the 28th day of the sub-acute oral toxicity study, the selected group of mice was sacriced with intraperitoneal administration of 30 mg per kg phenobarbital, and organs such as the pancreas, kidney, spleen, heart, and liver were surgically detached to perform the histopathological studies. The isolated sections were examined carefully under a microscope using slides. The histopathological changeover deviations from the normal group were carefully obtained.
Experimental animals, induction of diabetes, and insulin assay
Male Wistar rats, weighing between 180 and 200 g ( Hypoglycemic activity in non-diabetic fasted rats (OGTT) 22 The rats were fasted and divided into eight groups of six animals each. The group I animals received only vehicle (0.9% w/v saline) orally in a volume of 0. By the end of the experimental duration, blood was withdrawn by retro orbital puncture and centrifuged using a rapid centrifuge (REMI-CM12) at 5000 rpm. Serum glucose was estimated on the 14th day using a fully automatic biochemistry analyzer (SPHEARA-ACCUREX455). Simultaneously, the fasting serum insulin was estimated by following the method described by Andersen et al., 1993 (ref. 23 ) using a fully automatic enzyme linked immunoassay (ELISA). On the 15th day of the study, the animals were sacriced and the important organs such as the pancreas, liver, etc., were removed and subjected to histopathological studies.
Statistical analysis
The results were expressed as mean AE S.E.M. For statistical analysis of the data group, the mean was compared using a oneway analysis of variance (ANOVA) followed by the Dunnett's test. p < 0.001 was considered to be statistically signicant.
Results and discussion
Fig . 1A shows the XRD prole of the green-synthesized CeO 2 NPs, which possess single-phase cubic uorite structure without any additional peaks. The several broad Bragg peaks correspond to (111), (200), (220), (311), (222), (400), (331), and (420) orientations, and they are precisely well indexed to the Joint Committee on Powder Diffraction Standards (JCPDS card no. 34-0394). This later crystallographic phase indicates that each cerium site is encountered by eight oxygen sites in the face-centered cubic arrangement, whereas each oxygen has the geometry of the tetrahedron cerium site. Using the Debye-Scherrer approximation and from the broadening of the peaks, the approximate crystallite size of the CeO 2 NPs was found to be 24 nm. FT-IR spectral analysis of pure white ZnO powder was carried out aer calcination at 200 C for 2 hours. belongs to alcohols (-OH). In the green synthesis of ZnO NPs, the Momordica charantia aqueous extract was used for the synthesis of the nanoparticles. Hence, in this method, chemical agents, surfactant, etc., were not used for the synthesis of the nanoparticles.
The functional groups present in the Ag NPs were identied by the FT-IR analysis. The Ag NPs contained functional groups 
such as alcohols (-OH) at 3490.2 cm
À1
, esters (C-O) at 1152.2 cm À1 , and amines and amides (N-H) at 1590.2 cm À1 (Fig. 2C) .
The average particle size was analysed using a particle size analyser, and the size distribution of the CeO 2 (Fig. 3A) , ZnO NPs (Fig. 3B) , and Ag NPs (Fig. 3C ) produced by the green method was observed. The nanomaterials were completely dispersed in the ethanol solution using an ultrasonicator for 30 minutes. The histograms of the PSA indicate that the average sizes of the obtained nanoparticles i.e., CeO 2 , ZnO NPs, and Ag NPs were 54, 55.8, and 22.5 nm, respectively. Fig. 4A depicts the SEM images of the green-synthesized CeO 2 NPs. It is obvious from the SEM image that the CeO 2 NPs were highly homogeneous and symmetrical in morphology with a spherical shape. Similarly, the ZnO NPs (Fig. 4B) were homogenous and symmetrical in the morphological shape with a uniform average grain size of less than 100 mm. The greensynthesized Ag NPs were well distributed without any aggregation and acquired a spherical shape (Fig. 4C) .
Isolated tissues, including pancreas, kidney, spleen, heart, and liver, of female mice were investigated aer exposure to ZnO NPs, CeO 2 , and Ag NPs and compared with those of the control group. 24 Aer dissection, the individual organs were weighed and no signicant differences between the body weights of animals and (Table 4 ) organ weights of the control Fig. 5 Histopathology of female mice pancreas, kidney, spleen, heart and liver for normal control group (A1, B1, C1, D1, and E1); histopathology of pancreas, kidney, spleen, heart and liver for ZnO NPs treated group (A2, B2, C2, D2, and E2); histopathology of pancreas, kidney, spleen, heart and liver for CeO 2 NPs treated group (A3, B3, C3, D3, and E3); histopathology of pancreas, kidney, spleen, heart and liver for Ag NPs treated group (A4, B4, C4, D4, and E4).
and treated groups were observed (Table 5) . Histopathology was performed to determine the effect of nanoparticles on the isolated organs. It was found that the histological sections (pancreas, kidney, spleen, heart, and liver) of the treated groups were similar to those of the control group (Fig. 5) . The results distinctly indicate that the ZnO NPs, CeO 2 , and Ag NPs were coated with non-toxic plant extract, thus demonstrating the safe and therapeutic applications of these green-synthesized nanoparticles. As per the OECD guideline number 425, in vivo subacute oral toxicity studies of the green-synthesized ZnO NPs, CeO 2 , and Ag NPs at three different dose levels were carried out. Further, it was found that oral administration of the greensynthesized nanoparticles did not bring about changes in the organ weight, abnormal growth, inammation, and structural changes in organs; this indicated the biocompatible and nontoxic nature of the nanoparticles. There were no histopathological abnormalities noted.
In view of the oral glucose tolerance test (OGTT), ZnO, CeO 2 , and Ag NPs were subjected to hypoglycemic activity testing at two dose levels (100 and 200 mg kg À1 , respectively) as shown in The data are expressed as mean AE S.E.M.; n ¼ 6 in each group. b p < 0.001, signicant when compared to normal control. The data are expressed as mean AE S.E.M.; n ¼ 6 in each group. b p < 0.001, signicant when compared to diabetic control. Table 1 . From the results of the OGTT study, it was conrmed that the ZnO NPs, CeO 2 NPs, and Ag NPs did not show any hypoglycemic activity in the untreated normal rats. Table 2 demonstrates the effect of ZnO, CeO 2 NPs, and Ag NPs on the glucose levels of normal and STZ-induced diabetic rats. The control group rats (normal control group) exhibited normal blood glucose levels, whereas the STZ-induced diabetic rats (diabetic control group) showed considerably greater levels than those of the normal control rats. 25 The occurrence of the hyperglycemic condition has resulted in uncontrolled glucose control brought on by the change in cellular metabolism in diabetic rats. 26 Note that diabetic rats treated with Ag NPs and ZnO NPs altogether (p < 0.001) brought the biochemical parameters to the normal level, demonstrating the benecial outcome of Ag NPs as well as ZnO NPs. The blood glucose levels were decreased at a dose range of 200 mg kg À1 of ZnO and Ag NPs, whereas the CeO 2 NPs showed less anti-diabetic activity in the STZ-induced diabetic rats. Oral administration of the ZnO NPs and Ag NPs for a period of 14 days produced a signicant reduction in the blood glucose levels as compared to that of the MC extract. Fasting insulin levels in the Ag NP-and ZnO NP-treated diabetic rats restored the levels signicantly (p < 0.001) to normalcy as compared to the diabetic control group and CeO 2 NP-and MC-treated group rats ( Table 3 ). The promising mechanism by which the NPs showed antidiabetic effects could be via potentiation of the pancreatic secretion of insulin from the existing b-cells of the islets, 27 as was apparent via the critical increment in the level of insulin in the Ag NP-and ZnO NPtreated animal groups. group VII and VIII, neither in number nor in the distance across, from those of the normal control group.
In the diabetic control group, a decline in the quantity of b cells was seen as compared to that in the normal control group rats (Fig. 6A and B) . The harm or putrefaction of the b cells was brought about by the streptozotocin used to prompt diabetes. 
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Conclusion
In the present study, we evaluated the toxic effects of the greensynthesized ZnO NPs, CeO 2 NPs, and Ag NPs. Upon repeated administration, the NPs did not produce any mortality or indication of toxicity, as evaluated by the behaviour of albino mice and the histopathological microscopic examination of the isolated organs. As per the current study results, the administered green-synthesized ZnO NPs and Ag NPs showed potent anti-hyperglycemic properties as compared to the MC extract CeO 2 NPs and likewise improved different entanglements of diabetes. Current global excitement in the use of eco-friendly and cost-effective resources drives the application of highly hailed medicinal plants to direct the green synthesis of nanoparticles that acquire diverse pharmacological properties. Accordingly, the CeO 2 , ZnO, and Ag NPs were synthesized and characterized using XRD, FT-IR, PSA, and SEM. In addition, the hypothesis of the synthesis of these nanoparticles was to associate green synthesis (enhanced biological properties) with a natural plant (non-toxic and chemically inert) and to increase the surface area of the drug to achieve greater and potent therapeutic efficacy. Hence, comparatively, it is recommended that the Ag NPs and ZnO NPs are more potent than the plain extract, CeO 2 NPs, and may be utilized as compelling nanomedicines that may be perfect alternatives to the crude extract for treatment of diabetes mellitus. However, further pharmacokinetic studies need to be explored. 
